Loading stock data…
$13.96-0.14 (-0.96%)
QuidelOrtho Corporation provides diagnostic testing solutions.
QuidelOrtho Corporation in the Healthcare sector is trading at $13.96 with a market capitalization of $918M. Wall Street consensus targets $14.67 (3 analysts), implying a +5.0% move over the next 12 months. The stock is currently near its 52-week low of $9.92, remaining 19.5% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 80 is overbought against a weak tape. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $630.90M↑ | $619.80M↓ | $723.60M↑ | $699.90M↑ | $613.90M |
| Gross Profit | $272.90M↑ | $263.80M↓ | $320.40M↓ | $335.60M↑ | $274.90M |
| Operating Income | -$15.30M↑ | -$27.40M↑ | -$37.30M↓ | $45.20M↑ | -$1.80M |
| Net Income | -$92.90M↓ | -$91.80M↑ | -$130.70M↑ | -$733.00M↓ | -$255.40M |
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments...